GRM5 and brain ischemia: The observed neuroprotective effects of a selective mGluR5 agonist (R,S)-2-chloro-5-hydroxyphenylglycine (CHPG) application in adult rat brain ischemia was linked to its anti-apoptotic properties, contrasting with the outcomes in neonatal rats [30].